Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Safety and Pharmacokinetic Study of XRP6258 (Cabazitaxel) In Advanced Solid Tumor Patients With Varying Degrees of Hepatic Impairment

NCT01140607 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01140607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01140607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Safety and Pharmacokinetic Study of XRP6258 (Cabazitaxel) In Advanced Solid Tumor Patients With Varying Degrees of Hepatic Impairment
Lead sponsor
Sanofi
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2010
Completion date
July 31, 2014
Enrollment
56 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm malignant